Navigation Links
Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders
Date:4/21/2011

ion of a May 12th consent deadline underscores the conclusion that Valeant is trying to rush Cephalon shareholders into a decision that may not be in your best interests
  • This is all about value for Cephalon shareholders – your current Board is best positioned to consider the Valeant non-binding proposal, is presently undertaking a review of all of Cephalon's alternatives and options and is focused on maximizing value for all Cephalon shareholders

  • Protect the value of your investment.  Do not consent to Valeant's attempt to put its hand-picked slate on your Board.  Maximize the value of your shares by supporting your current Board of Directors – please sign, date and mail the enclosed WHITE Consent Revocation Card immediately.VALEANT'S $73 PER SHARE PROPOSAL IS INADEQUATE AND NOT IN YOUR BEST INTERESTSThe Board has determined that Valeant's proposed price significantly undervalues the Company, including the greater value the Board believes is achievable from the Company's strategic plan, especially the value of the Company's diversified portfolio of marketed and pipeline products in the therapeutic areas of CNS, pain, oncology, immunology and regenerative medicine.  

    By Valeant's own admission, its analysis of Cephalon's value is based on a worst-case scenario for Cephalon, which the Board believes is an inappropriate methodology.  Even with this approach, Valeant's chief executive officer confidently noted during an investor conference call on March 30, 2011 that Valeant's proposal minimizes downside value risk for Valeant and its shareholders even if all of Valeant's worst-case scenario assumptions for Cephalon's business are realized.

    You should be aware that:

  • The 30-day average Cephalon share price of $56.74 on which Valeant based its non-binding proposal is near the stock's 52-week low and Valeant's non-binding proposal represents virtually no premium to Cephalon's 52-week high.
  • '/>"/>

    SOURCE Cephalon, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Cephalon Quarterly Conference Call Invitation
    2. Cephalon Concludes All Outstanding Federal and State Government Investigations into the Companys Sales and Promotional Practices
    3. $425 Million Cephalon Civil Settlement and Criminal Fine; In Americas Largest
    4. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
    5. Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
    6. Cephalon Reports Another Strong Quarter
    7. Cephalon, Inc. to Webcast Analyst Day
    8. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
    9. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
    10. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
    11. Cephalons New Product Launches Pace Record 2008 Sales
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... -- Think Drinks are a neuroscience-backed drink regimen developed ... are the first functional focus beverage to give users ... to the temporary fix associated with energy drinks. truBrain ... 2014, with hopes to raise $50,000 over the course ... http://photos.prnewswire.com/prnh/20140723/129697 Think Drinks were designed ...
    (Date:7/23/2014)... July 23, 2014  AuraSense Therapeutics, the pioneer ... gene regulatory and immunotherapeutic agents, announced today ... AuraSense Therapeutics, executive leadership team as chief ... Prior to joining AuraSense Therapeutics, Mr. Snyder ... Officer of Cellular Dynamics International Inc., where ...
    (Date:7/23/2014)... Shimadzu Scientific Instruments has launched the ... developed jointly with Ajinomoto Co. Inc. Offering simultaneous ... amino acids in nine minutes, drastically enhancing laboratory ... utilizing a fast application-specific column and an LCMS-2020 ... even under conditions with difficult samples that contain ...
    (Date:7/23/2014)... 23, 2014 Last year, Formedix ... a leading global provider of data management solutions for ... a leading-edge system for electronic data capture (EDC) and ... design and study execution tools added TrialMaster to its ... anticipated version of Transform for TrialMaster, is being released ...
    Breaking Biology Technology:truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo 2AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer 2Shimadzu's New UF-Amino Station Provides High-Speed, Multi-Component Analysis of Amino Acids in Food & Beverage and Pharmaceutical Testing 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 2Formedix and OmniComm Systems® Partnership Strengthened with the Release of Enhanced TrialMaster® Integration for EDC Build 3
    ... physics of the perfect pizza toss and will use ... thinner that a human hair. , Mr Daniel (Kuang-Chen) ... Friend and Senior Lecturer Leslie Yeo, videotaped a professional ... Research Laboratory, then calculated how best to describe the ...
    ... WAYNE, Pa., April 27 Encorium Group, Inc. ... full-service multinational contract research organization (CRO) that provides design, ... registries to many of the world,s leading pharmaceutical companies, ... new business contracts, consisting of both new business contracts ...
    ... ", or "the Company") (OTC Bulletin Board: SNBP) is ... seven key patents from Company CEO Dr. Lequn Huang ... enhance Sinobiopharma,s ability to execute on its mission of ... for the following:, , ...
    Cached Biology Technology:Pizza tossing art unlocks secrets of tiny motors 2Encorium Group Signs Approximately $2.0 Million of New Business Contracts 2Encorium Group Signs Approximately $2.0 Million of New Business Contracts 3Sinobiopharma Secures Rights to Seven Key Patents 2
    (Date:7/23/2014)... health risk warning for Yellowknife and surrounding area because ... fires. In the image taken by the Aqua ... patterns. Fire is an obvious health hazard, but ... so obvious and its effects are insidious. , The ... crop, structure, tires, waste or wood burning) is a ...
    (Date:7/23/2014)... , , , , ... , , , , ... extend healthy lifespan. The idea, they argue, would be to target the... , , ... , , , , , ... , , , , , , , Medicine focuses almost ...
    (Date:7/23/2014)... 23, 2014 Migratory songbirds are disappearing, and though ... change, loss of habitat, acid rain and light pollution, ... where do these birds go once they leave their ... along the way? , To answer this question, a ... the first ever migratory connectivity map produced for a ...
    Breaking Biology News(10 mins):Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5York University researchers use bird 'backpacks' to put wood thrushes migration on the map 2
    ... clinical trial, a new drug that selectively blocks ... acute kidney transplant rejection as cyclosporine, the standard ... experimental drug, a co-stimulatory blocker called belatacept (LEA29Y), ... of the toxic side effects associated with standard ...
    ... and chimpanzees both pass on "traditions" to other members ... feeding behaviour. The findings add to evidence that cultural ... involved killerwhales at Marineland in Niagara Falls in Ontario, ... to catch birds, and passed the strategy on to ...
    ... mast cells, known to play a central role in ... that can kill these cells by programming them to ... move researchers another step closer to understanding the life ... new treatments for allergy and inflammatory responses in arthritis, ...
    Cached Biology News:New type of rejection blocker protects kidneys after transplant 2New type of rejection blocker protects kidneys after transplant 3New type of rejection blocker protects kidneys after transplant 4More animals join the learning circle 2Climate model links higher temperatures to prehistoric extinction 2
    ... This product has been developed to significantly ... labeled proteins. Stability is increased at ... 2-8 centigrade. This product is subjected ... mercury or azide. This formulation insures ...
    This unique buffer provides a gentle method for removal of primary and secondary antibodies to allow several reprobings on the same membrane. Gentle buffer will not alter the antigen for subsequent i...
    ... for fine-tuning the bombardment conditions for your ... when you are first using the PDS-1000 ... g each of 0.6 micrometer, 1.0 micrometer, ... each of 9 rupture disks, 500 macrocarriers, ...
    ... Gene Expression (SAGE) is a powerful ... a cost-effective outsourcing solution for sequencing ... Agencourt's SAGE sequencing service provides our ... long Phred20 read lengths (40 SAGE ...
    Biology Products: